Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the philadelphia translocation and can induce a CML‐specific primary cytotoxic T‐cell response
暂无分享,去创建一个
D. Niederwieser | G. Schuler | N. Romani | S. Ebner | B. Eibl | A. Gächter | G. Böck | C. Duba | M. Erdel
[1] F. Sallusto,et al. Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.
[2] D. Niederwieser,et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1996, Journal of immunological methods.
[3] R. Steinman,et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.
[4] A. Sette,et al. Specific human cellular immunity to bcr-abl oncogene-derived peptides. , 1996, Blood.
[5] J. Mayordomo,et al. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity , 1996, The Journal of experimental medicine.
[6] Edgar G. Engleman,et al. Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.
[7] L. Zitvogel,et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity , 1995, Nature Medicine.
[8] J. Ozols,et al. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Melief,et al. Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. , 1995, Leukemia.
[10] Liangji Zhou,et al. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. , 1995, Journal of immunology.
[11] S. Beissert,et al. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? , 1995, Immunology today.
[12] R. Steinman,et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. , 1994, The Journal of clinical investigation.
[13] R. Steinman,et al. Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.
[14] M. Moser,et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo , 1994, European journal of immunology.
[15] S. Rosenberg,et al. Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells , 1994, European journal of immunology.
[16] C. Witt,et al. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. , 1993, Bone marrow transplantation.
[17] S. Gaggl,et al. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens , 1993 .
[18] T. Schumacher,et al. Mechanisms of induction of primary virus‐specific cytotoxic T lymphocyte responses , 1992, European journal of immunology.
[19] Liangji Zhou,et al. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. , 1992, Journal of immunology.
[20] Barrett Aj,et al. Immune responses to chronic myeloid leukaemia. , 1992 .
[21] Wei Chen,et al. T-cell immunity to the joining region of p210BCR-ABL protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] W. Chen. T cell immunity to the joining region of p210^ protein. , 1992 .
[23] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[24] W. Wilmanns,et al. Donor Leukocyte Transfusions for Treatment of Recurrent Chronic Myelogenous Leukemia in Marrow Transplant Patients , 1990 .
[25] R. Steinman,et al. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells , 1990, The Journal of experimental medicine.
[26] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[27] B. Askonas,et al. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro , 1989, The Journal of experimental medicine.
[28] C. Melief,et al. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses , 1988, European journal of immunology.
[29] A. Butturini,et al. Graft-versus-leukemia following bone marrow transplantation. , 1987, Bone marrow transplantation.
[30] R. Steinman,et al. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells , 1987, The Journal of experimental medicine.
[31] A. Mes-Masson,et al. Role of the abl oncogene in chronic myelogenous leukemia. , 1987, Advances in cancer research.
[32] O. Witte,et al. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Kantarjian,et al. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. , 1986, The New England journal of medicine.
[34] N. Heisterkamp,et al. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. , 1985, The New England journal of medicine.
[35] S. Jhanwar,et al. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. , 1985, Blood.
[36] R. Steinman,et al. Protein-specific helper T-lymphocyte formation initiated by dendritic cells. , 1985, Science.
[37] E. Canaani,et al. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.
[38] Kees Stam,et al. Structural organization of the bcr gene and its role in the Ph′ translocation , 1985, Nature.
[39] D. Golde,et al. Chronic myelogenous leukemia: recent advances. , 1985, Blood.
[40] Susan M. Watanabe,et al. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.
[41] J. Stephenson,et al. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia , 1983, Nature.
[42] T. Waldmann,et al. Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. , 1983, The New England journal of medicine.
[43] E. Reinherz,et al. T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia , 1983 .
[44] J. Stephenson,et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.
[45] L. Eisenberg,et al. Ph1-POSITIVE T LYMPHOBLASTIC TRANSFORMATION OF CHRONIC GRANULOCYTIC LEUKAEMIA IN A LYMPH NODE , 1982, The Lancet.
[46] L. Kearney,et al. T-CELL CYTOGENETICS IN CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.
[47] V. Najfeld,et al. Involvement of the B-lymphoid system in chronic myelogenous leukaemia , 1980, Nature.
[48] C. Huber,et al. Linear density gradient separation of human lymphocyte subsets , 1977, European journal of immunology.
[49] Williams Ln. Semi-security and psychiatric hospitals. , 1974 .
[50] D. Mattingly,et al. AGE AND SLEEP. , 1964, Lancet.